Optimer Pharmaceuticals (OPTR)

14.95 -0.18  -1.19%  May 31, 5:21PM Go Pro
Watch this stock

Optimer Pharmaceuticals News

Analysis of Data from Two Phase 3 Studies Shows DIFICIDĀ® Offered Faster Diarrheal Symptom Improvement than Oral Vancomycin in Patients with Cancer Being Treated for Clostridium difficile-Associated Diarrhea (CDAD)
PR Newswire about 15 days ago

SAN DIEGO, May 16, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (OPTR) today announced the results of a retrospective subpopulation analysis of 183 patients with cancer from the company's ...

Loss at Optimer in 1Q
about 20 days ago

Optimer Pharmaceuticals (OPTR) Tops Q1 EPS by 15c
Street Insider about 21 days ago

Get News for

Recent Quotes

Symbol Price Chg Chg % Market Cap
OPTR 14.95 -0.18 -1.19% 707.33M
OPNT 24.96 -0.68 -2.65% 578.44M
OPLK 12.81 +0.14 +1.10% 243.52M
OPHC 0.6402 -0.02 -3.29% 14.65M
OPEN 39.64 +0.00 +0.00% 893.88M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close